ORIGINAL ARTICLE: Occasional Antiphospholipid Antibody Positive Patients with Recurrent Pregnancy Loss Also Merit Aspirin Therapy: A Retrospective Cohort‐Control Study
- 10 February 2008
- journal article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 59 (3) , 235-241
Abstract
Problem: It is well known that treatment with aspirin plus heparin is effective for patients with antiphospholipid syndrome (APS) to prevent pregnancy loss. However, it is unclear if occasional antiphospholipid antibodies (aPL) are a risk factor and whether patients with aPL at one time point but not diagnosed as APS should be treated.Method of study: We therefore studied whether aspirin alone is effective in patients with occasional aPL who did not meet the criteria for APS. We compared live birth rates between 52 patients with occasional aPL treated with aspirin and 672 unexplained patients with no medication. Patients in both group had a history of two or three pregnancy losses.Results: In all, 44 of 52 patients (84.6%) with occasional aPL could experience live birth when treated with aspirin alone. 509 of 672 patients (75.7%) with unexplained pregnancy losses could have babies. When miscarriage cases caused by an abnormal embryonic karyotype were excluded, the success rates were 95.7% (44/46) and 81.2% (509/621), respectively. The live birth rate in patients with occasional aPL treated with aspirin was significantly higher than that in unexplained patients with no medication (P = 0.008).Conclusion: We therefore conclude that aspirin is also useful in patients with occasional aPL but not APS.Keywords
This publication has 28 references indexed in Scilit:
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Paternal uniparental disomy of chromosome 14 and unique exchange of chromosome 7 in cases of spontaneous abortionJournal of Human Genetics, 2005
- Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitroAmerican Journal of Obstetrics and Gynecology, 2004
- Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocationsFertility and Sterility, 2004
- HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriageMolecular Human Reproduction, 2001
- Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriageFertility and Sterility, 2001
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Anti β2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significanceLupus, 1996
- Preconceptional natural-killer-cell activity as a predictor of miscarriageThe Lancet, 1995
- LUPUS ANTICOAGULANT AND PREGNANCY MANAGEMENTThe Lancet, 1984